You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myasthenia Gravis

Showing 26 - 50 of 423
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ocular Myasthenia Gravis Trial in Xi'an (Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus,

Recruiting
  • Ocular Myasthenia Gravis
  • Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)
  • Xi'an, Shaanxi, China
    Tangdu Hospotal
Aug 16, 2022

Myasthenia Gravis, Generalized Trial in United States (Descartes-08)

Recruiting
  • Myasthenia Gravis, Generalized
  • Carlsbad, California
  • +8 more
Jan 27, 2023

MuSK Myasthenia Gravis Trial (MuSK-CAART)

Not yet recruiting
  • MuSK Myasthenia Gravis
  • MuSK-CAART
  • (no location specified)
Jul 5, 2022

Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

Not yet recruiting
  • Generalized Myasthenia Gravis
  • zilucoplan (RA101495)
  • (no location specified)
Aug 22, 2022

Generalized Myasthenia Gravis Trial in Spain, United States (ALXN1720, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • ALXN1720
  • Placebo
  • Gainesville, Georgia
  • +7 more
Dec 20, 2022

Sensitivity of Repetitive Nerve Stimulation Performed in Evening

Recruiting
  • Myasthenia Gravis
    • Kraków, Lesser Poland, Poland
      Jagiellonian University Medical College, Department of Neurology
    Aug 13, 2022

    Exercise in Autoimmune Myasthenia Gravis and Myasthenic

    Completed
    • Autoimmune Myasthenia Gravis
    • +3 more
      • Paris, France
        Online Questionnaire
      Jun 3, 2022

      Interleukin and Autoantibodies in Myasthenia Gravis.

      Not yet recruiting
      • Myasthenia Gravis
      • real time PCR , ELISA
      • (no location specified)
      Apr 27, 2022

      Descriptive Analysis of Real-world Data Collected With ME&MGopen

      Not yet recruiting
      • Myasthenia Gravis
      • Me&MGopen smartphone application
      • London, Greater London, United Kingdom
        Lindus Health
      Dec 9, 2022

      Myasthenia Gravis, MuSK Trial in Cleveland, Philadelphia (Amifampridine Phosphate)

      Active, not recruiting
      • Myasthenia Gravis, MuSK
      • Amifampridine Phosphate
      • Cleveland, Ohio
      • +1 more
      Jul 21, 2022

      Predictors and Prognostic Factors of Myasthenia Gravis Outcome

      Recruiting
      • Myasthenia Gravis
      • +11 more
      • Drug treatment of myasthenia gravis and treatment of crisis
      • Assiut, Egypt
        Assiut University
      Feb 22, 2022

      Myasthenia Gravis, Generalized Trial in China (Tocilizumab Injectable Product)

      Recruiting
      • Myasthenia Gravis, Generalized
      • Tocilizumab Injectable Product
      • Beijing, Beijing, China
      • +5 more
      Sep 15, 2022

      Myasthenia Gravis, Myasthenia Gravis, Juvenile Form, Myasthenia Gravis, Generalized Trial in Japan, Netherlands, United States

      Active, not recruiting
      Has Results
      • Myasthenia Gravis
      • +2 more
      • Los Angeles, California
      • +15 more
      Aug 1, 2022

      Myasthenia Gravis Trial in GuangZhou (Azathioprine, Leflunomide)

      Completed
      • Myasthenia Gravis
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital, SUN YAT-SEN UNIVERSITY
      Apr 6, 2022

      Refractory Myasthenia Gravis, Rituximab Trial in Guangzhou (Rituximab)

      Recruiting
      • Refractory Myasthenia Gravis
      • Rituximab
      • Guangzhou, China
        First Affiliated Hospital, Sun Yat-Sen University
      Apr 26, 2022

      The FBIndex - A Feasibility Study

      Not yet recruiting
      • Inclusion Body Myositis
      • +5 more
      • The risk of falls
      • (no location specified)
      May 26, 2023

      Guillain-Barre Syndrome, Myasthenia Gravis Trial in Mansoura (diaphragmatic ultrasound)

      Completed
      • Guillain-Barre Syndrome
      • Myasthenia Gravis
      • diaphragmatic ultrasound
      • Mansoura, Not In US Or Canada, Egypt
        Mansoura University Hospitals
      May 13, 2022

      Myasthenia Gravis Trial in Shanghai (HBM9161 Injection (680mg), HBM9161 Drug Product (340mg))

      Not yet recruiting
      • Myasthenia Gravis
      • HBM9161 Injection (680mg)
      • HBM9161 Drug Product (340mg)
      • Shanghai, Shanghai, China
        Huashan Hospital, Fudan University
      Apr 12, 2022

      Generalized Myasthenia Gravis Trial in Phoenix (ALXN1830, Placebo)

      Withdrawn
      • Generalized Myasthenia Gravis
      • Phoenix, Arizona
        Clinical Study Site
      Feb 2, 2022

      Generalized Myasthenia Gravis Trial in Carlsbad (Batoclimab 680 mg SC weekly, Batoclimab 340 mg SC weekly, Matching Placebo SC)

      Recruiting
      • Generalized Myasthenia Gravis
      • Batoclimab 680 mg SC weekly
      • +3 more
      • Carlsbad, California
      • +14 more
      Jan 31, 2023

      VDR Gene Polymorphisms and Risk and Features of MG in Han

      Completed
      • Myasthenia Gravis, Ocular
      • Gene Polymorphism
      • Genotype analysis for VDR rs1544410, rs2228570, rs731236, and rs7975232 polymorphisms
      • Beijing, China
        Beijing Tongren Hospital
      May 15, 2022

      Burden of Disease in Myasthenia Gravis

      Completed
      • Myasthenia Gravis
        • Berlin-Mitte, Germany
          NeuroCure Clinical Research Center (NCRC), Charité University, B
        Dec 15, 2021

        Systemic Myasthenia Gravis Trial in Beijing (RC18 160mg, RC18 240 mg)

        Active, not recruiting
        • Systemic Myasthenia Gravis
        • RC18 160mg
        • RC18 240 mg
        • Beijing, Beijing, China
          Beijing Tiantan Hospital,Capital Medical University
        Jan 9, 2022

        Generalized Myasthenia Gravis Trial in Worldwide (Efgartigimod IV)

        Recruiting
        • Generalized Myasthenia Gravis
        • Efgartigimod IV
        • Wien, Austria
        • +12 more
        Jul 19, 2022

        Ocular Myasthenia Gravis, Cytomegalovirus Infections Trial in Guangzhou (Serum acetylcholine receptor antibody, erythrocyte

        Recruiting
        • Ocular Myasthenia Gravis
        • Cytomegalovirus Infections
        • Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation
        • Guangzhou, Guangdong, China
          The First Affiliated Hospital of Jinan University
        Oct 20, 2021